Novel Arylsulfoanilide−Oxindole Hybrid as an Anticancer Agent That Inhibits Translation Initiation
Amarnath Natarajan, Yuhong Guo, Frederick Harbinski et al. · Journal of Medicinal Chemistry · 2004
Structure-activity relationship studies of substituted arylsulfoanilides as antiproliferatives, which are mediated by the partial depletion of intracellular Ca(2+) stores, resulted in the identification of compounds with micromolar activity against lung cancer cells in a growth inhibition assay. Incorporating the substitution pattern of the best arylsulfoanilides onto the 3-phenyloxindole scaffold resulted in a potent arylsulfoanilide-oxindole hybrid, 27. Compound 27 inhibits cancer cell growth by partial depletion of intracellular Ca(2+) stores and phosphorylation of eIF2alpha.
Cited by 190 works. doi:10.1021/jm0496234
Authors
- Amarnath Natarajan
- Yuhong Guo
- Frederick Harbinski
- Yun-Hua Fan
- Han Chen
- Lia Luus
- Jana Diercks
- Hüseyin Aktaş
- Michael Chorev
- José A. Halperin
References
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
- Ras Links Growth Factor Signaling to the Cell Cycle Machinery via Regulation of Cyclin D1 and the Cdk Inhibitor p27KIP1
- Anticancer and Antiviral Sulfonamides
- eIF4E expression in tumors: its possible role in progression of malignancies
- Receptor-activated Ca2+ influx. Two independently regulated mechanisms of influx stimulation coexist in neurosecretory PC12 cells.
- Translational control: the cancer connection
- Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
- Clotrimazole inhibits cell proliferation in vitro and in vivo
- Direct Synthesis of Sulfonamides and Activated Sulfonate Esters from Sulfonic Acids
- Depletion of intracellular Ca 2+ stores, phosphorylation of eIF2α, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole